SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Targacept (TRGT)
An SI Board Since September 2006
Posts SubjectMarks Bans
40 6 0
Emcee:  keokalani'nui Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
40WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (Nasdaq: TRGT - News), a cnigel bates1/11/2010
39WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT - News), a cnigel bates12/10/2009
38AstraZeneca and Targacept Form Global Collaboration and License Agreement for Lanigel bates12/3/2009
37Heres a great article on TRGT from seeking alpha seekingalpha.comdrstck10/22/2009
36The new data set showed the HAMD improvement in real numbers vs. the prior news kenhott10/19/2009
35>>Targacept Presents Data from Highly Successful Phase 2b Trial of TC-5214tuck10/16/2009
34Targacept's TC-5214 Achieves All Primary and Secondary Outcome Measures in Pkenhott7/15/2009
33BVF buying some chunks here...mopgcw7/14/2009
32Anyone still following TRGT? The results of the AZ were inconclusive. How doesSam Quentin9/16/2008
31>>Targacept Announces Results of Phase II Study of TC-2696 in Postoperativtuck12/3/2007
30Yep.Wish they make a deal on this preclin inflammation cpd with Pfizer or someondr.praveen7/31/2007
29This would be retained by trgt for development on its own I take it.keokalani'nui7/31/2007
28The alpha7 nicotinic acetylcholine receptor as a pharmacological target for infldr.praveen7/31/2007
27Some big biobucks in that deal.keokalani'nui7/27/2007
26GlaxoSmithKline and Targacept Form Alliance in Therapeutics for CNS-related Disodr.praveen7/27/2007
25athenagen.comdr.praveen4/5/2007
24In too early out too early (acad). Story of my life.keokalani'nui3/20/2007
23Acadia effect still going on...eomdr.praveen3/20/2007
22I'm comfortable holding my trgt. I really am put off by the CEO or whoever keokalani'nui1/27/2007
21Thanks! I see they actually did report the results in November. They just didntuck1/26/2007
20<i>Here are my, uh, thoughts a couple weeks old. If they answer your queskeokalani'nui1/26/2007
19Starting to look at TRGT. From the 3rd Q PR posted by George: >>Completetuck1/26/2007
188-K <i>License Agreement Under the License Agreement, Yale granted to tkeokalani'nui1/26/2007
17Agree, might be the most interesting program of all. (Could conceivably add $1+keokalani'nui1/8/2007
16Targacept Initiates Phase I Clinical Trial of TC-2216 Monday January 8, 8:55 am dr.praveen1/8/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News